Various hair changes have been reported in human immunodeficiency virus (HIV)infected patients.1-4 The prevalence of these changes, however, has not been studied.
Methods
The Women's Interagency HIV Study (WIHS) is a multicenter prospective study of women in the United States who have HIV or are at risk for HIV disease.5 During the evaluation period of April 2000 through September 2000 a hair questionnaire was administered to 336 HIV-infected and 91 nonHIV-infected (HIV-noninfected) women in the Northern California WIHS.
The questionnaire focused on personal and family history of hair loss, current assessment of hair density, change in hair characteristics, eyebrow and eyelash length, and hair grooming practices. Information on demographics, medication use, and laboratory values was also assessed. Women infected with HIV who were taking a combination of antiretroviral medications that included a protease inhibitor or nonnucleoside reverse transcriptase inhibitor were labeled as being on highly active antiretroviral therapy (HAART).
For bivariate . . . [Full Text of this Article]
Results
Comment